Decision Analysis of the Benefits and Costs of Screening for Prostate Cancer

Abstract

This annual report details the progress that has been made between August 2012 and August 2013, the fourth year of the Physician Research Training Award entitled Decision analysis of the benefits and costs of screening for prostate cancer . The goal of the proposed research is to develop a decision analytic model of PSA screening for prostate cancer. This model will permit the analysis of the effect of various PSA screening strategies on life expectancy (LE), quality-adjusted LE (QALE), and the cost-effectiveness of screening. The comparator will be a natural history model of unscreened, conservatively-treated prostate cancer based on primary data. It is hypothesized that the optimal screening strateg(ies) for prostate cancer will be dependent not only upon mortality benefit, but also upon the value patients place on health states and costs.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2013
Accession Number
ADA612325

Entities

People

  • Julia H. Hayes

Organizations

  • Dana–Farber Cancer Institute

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Cost Effectiveness
  • Data Analysis
  • Diseases And Disorders
  • Health
  • Health Care
  • Health Services
  • Lead Time
  • Medical Personnel
  • Natural History
  • Neoplasms
  • Prostate Cancer
  • Proton Beams
  • Public Health
  • Quality Of Life
  • Radiation
  • Therapy

Readers

  • Academic Conference Management
  • Life Cycle Cost Analysis
  • Oncology and Biomarker-Based Cancer Detection.